Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 31 (29) 3664-72
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
3
Parents:
346  
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
K05CA-142885, U24 CA114740, CA-114740, P30 CA015083, P30 CA016058, K05 CA142885  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-89803, NCCTG-N0147
Phases:
3
Keywords:
Gic7, To2, To15, Original Reports, Gastrointestinal Cancer